Yanwen Jiang
Distinguished Scientist Genentech
Seminars
Thursday 5th February 2026
From Assay to Action – Making MRD a Practical Tool for Treatment Decisions in Hematology
11:55 am
Bridging assay development and translational research to define clinically meaningful MRD cutoffs and endpoints
Designing MRD-guided clinical trials to inform treatment decisions, including escalation, consolidation & de-escalation strategies
Addressing turnaround time, cost and implementation challenges to ensure MRD assays can move fri om trials into routine practice
